Outcomes and management costs in patients hospitalized for skin and skin-structure infections

American Journal of Infection Control

Volumn 39, Issue 1, 2011, Pages 42-49

  Itani, Kamal M F ^a   Merchant, Sanjay ^b   Lin, Swu Jane ^c,d   Akhras, Kasem ^b   Alandete, Juan Carlos ^e   Hatoum, Hind T ^c,d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c Hind T Hatoum and Company   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e Janssen Cilag Colombia   (Colombia)

Author keywords

gram negative; gram positive; length of stay; methicillin resistant Staphylococcus aureus; mixed infections; mortality; Pseudomonas aeruginosa; Skin and skin structures infections

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL SKIN DISEASE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; TREATMENT OUTCOME;

EID: 79551544535     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.03.018     Document Type: Article

References (18)

1. K. Levit, E. Stranges, K. Ryan, and A. Elixhauser HCUP Facts and Figures, 2006: Statistics on hospital-based care in the United States Available at: http://www.hcup-us.ahrq.gov/reports.jsp Accessed March 4, 2009
2. K.M.F. Itani MRSA and complicated skin and soft tissue infections J.A. Weigelt, MRSA 2008 Informa Healthcare New York 55 70
3. R.P. Rennie, R.N. Jones, and A.H. Mutnick Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000) Diagn Microbiol Infect Dis 45 2003 287 293
4. C.M. Chang, H.C. Lee, N.Y. Lee, I.W. Lee, C.J. Wu, and P.L. Chen Community-acquired Klebsiella pneumoniae complicated skin and soft tissue infections of extremities: emphasis on cirrhotic patients and gas formation Infection 36 2008 328 334
5. L. Lazzarini, E. Conti, G. Tositti, and F. de Lalla Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital J Infect 51 2005 383 389
6. J.J. Engemann, Y. Carmeli, S.E. Cosgrove, V.J. Fowler, M.Z. Bronstein, and S.L. Trivette Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection Clin Infect Dis 36 2003 592 598
7. K.S. Kaye, J.J. Engemann, E. Mozaffari, and Y. Carmeli Reference group choice and antibiotic resistance outcomes Emerg Infect Dis 10 2004 1125 1128
8. B.A. Lipsky, J.A. Weigelt, V. Gupta, A. Killian, and M.M. Peng Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes Infect Control Hosp Epidemiol 28 2007 1290 1298
9. M.J. DiNubile, and B.A. Lipsky Complicated infections of skin and skin structures: when the infection is more than skin deep J Antimicrob Chemother 53 Suppl 2 2004 ii37 ii50
10. G.J. Moet, R.N. Jones, D.J. Biedenbach, M.G. Stilwell, and T.R. Fritsche Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (19982004) Diagn Microbiol Infect Dis 57 2007 7 13
11. B.A. Lipsky, A.R. Berendt, H.G. Deery, J.M. Embil, W.S. Joseph, and A.W. Karchmer Diagnosis and treatment of diabetic foot infections Clin Infect Dis 39 2004 885 910
12. K. Itani, K.S. Akhras, R. Stellhorn, A. Quintana, D. Budd, and S. Merchant Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections Pharmacoeconomics 27 2009 421 430
13. L.G. Miller, F. Perdreau-Remington, A.S. Bayer, B. Diep, N. Tan, and K. Bharadwa Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation Clin Infect Dis 44 2007 471 482
14. J.C. McGregor, P.W. Kim, E.N. Perencevich, D.D. Bradham, J.P. Furuno, and K.S. Kaye Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms Am J Epidemiol 161 2005 483 493
15. D.J. Flournoy, J. Hinahon, G. Klein, L. Hall, and C.K. Murray Length of hospital stay in veteran surgical service patients with nosocomial infections J Natl Med Assoc 82 1990 265 270
16. E.E. Tredget, H.A. Shankowsky, R. Rennie, R.E. Burrell, and S. Logsetty Pseudomonas infections in the thermally injured patient Burns 30 2004 3 26
17. M.A. Wilson Skin and soft-tissue infections: impact of resistant gram-positive bacteria Am J Surg 186 2003 35S 41S
18. J. Edelsberg, A. Berger, D.J. Weber, R. Mallick, A. Kuznik, and G. Oster Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections Infect Control Hosp Epidemiol 29 2008 160 169